Skip to main content
. 2021 Jan;10(1):215–226. doi: 10.21037/tau-20-1134

Figure 1.

Figure 1

SNHG9 expression and clinicopathological features of PCa. (A) Wilcoxon rank sum test was used to analyze the difference expression of SNHG9 in PCa tissues and adjacent prostate tissues. (B) Wilcoxon signed rank sum test was used to detect the difference expression of SNHG9 in PCa tissues and adjacent prostate tissues. (C) Wilcoxon rank sum test was used to analyze the difference expression of SNHG9 in normal prostate tissues of GTEx combined with TCGA and PCa tissues of TCGA. (D) ROC curve showed the efficiency of SNHG9 expression level to distinguishing PCa tissue from non-tumor tissue. X-axis represents false positive rate, and Y-axis represents true positive rate.